NPI: 1316994734 · TIFFIN, OH 44883 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 05/30/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (SYSTEM DIRECTOR) |
| NPI Enumeration Date | 05/30/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,358 | $747K |
| 2019 | 26,310 | $795K |
| 2020 | 26,210 | $1.09M |
| 2021 | 33,191 | $1.38M |
| 2022 | 30,206 | $1.22M |
| 2023 | 133,000 | $4.68M |
| 2024 | 84,348 | $3.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 19,698 | 18,039 | $2.33M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 13,940 | 11,545 | $1.74M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 15,291 | 5,082 | $1.04M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7,697 | 5,911 | $1.03M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7,927 | 2,316 | $635K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,819 | 4,538 | $524K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,540 | 830 | $520K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,781 | 1,186 | $493K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6,259 | 2,235 | $453K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,359 | 1,009 | $345K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,752 | 997 | $271K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,211 | 1,154 | $209K |
| 80053 | Comprehensive metabolic panel | 17,315 | 13,754 | $168K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 546 | 276 | $167K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,593 | 3,160 | $166K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 619 | 415 | $158K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,831 | 1,939 | $157K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 819 | 651 | $150K |
| 41899 | Unlisted procedure, dentoalveolar structures | 115 | 107 | $132K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 700 | 597 | $119K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,129 | 2,720 | $118K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,587 | 3,157 | $95K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 511 | 344 | $88K |
| G0378 | Hospital observation service, per hour | 1,096 | 359 | $85K |
| 59025 | Fetal non-stress test | 515 | 353 | $82K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 4,880 | 4,021 | $68K |
| 80048 | Basic metabolic panel (calcium, ionized) | 8,188 | 6,568 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,839 | 2,302 | $64K |
| 80061 | Lipid panel | 2,538 | 2,233 | $62K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 23,977 | 18,687 | $61K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 520 | 320 | $56K |
| 36415 | Collection of venous blood by venipuncture | 32,101 | 24,843 | $56K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2,087 | 607 | $51K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,043 | 1,867 | $50K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 183 | 121 | $46K |
| 92526 | 670 | 249 | $42K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 390 | 302 | $38K |
| 85027 | 4,556 | 3,735 | $33K | |
| 71046 | Radiologic examination, chest; 2 views | 2,643 | 2,312 | $30K |
| 93242 | 383 | 300 | $28K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,141 | 7,128 | $28K |
| 97533 | 362 | 149 | $28K | |
| 74018 | 573 | 462 | $28K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 1,204 | 1,094 | $27K |
| 86900 | 1,013 | 797 | $26K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 178 | 90 | $26K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,701 | 1,458 | $25K |
| 80074 | 1,241 | 1,157 | $25K | |
| 86803 | 764 | 668 | $25K | |
| 93017 | 341 | 238 | $24K | |
| 97161 | 385 | 322 | $22K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 801 | 683 | $21K |
| 84703 | 2,623 | 2,217 | $20K | |
| 86780 | 895 | 784 | $20K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 370 | 313 | $19K |
| 97014 | 733 | 227 | $19K | |
| 93976 | 157 | 115 | $19K | |
| 84702 | 984 | 607 | $18K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,009 | 754 | $17K |
| 87070 | 780 | 633 | $17K | |
| 70496 | 62 | 38 | $16K | |
| 86850 | 1,097 | 894 | $16K | |
| 93243 | 369 | 295 | $16K | |
| 81001 | 12,449 | 10,154 | $13K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4,581 | 3,836 | $13K |
| 84484 | 5,207 | 3,229 | $13K | |
| 84439 | 966 | 802 | $12K | |
| 86140 | 855 | 644 | $12K | |
| 86762 | 549 | 471 | $11K | |
| 82607 | 627 | 546 | $11K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 617 | 592 | $11K |
| 82728 | 607 | 528 | $11K | |
| 87480 | 607 | 509 | $11K | |
| 86901 | 1,147 | 924 | $10K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 677 | 592 | $10K |
| 97166 | 122 | 102 | $10K | |
| 73630 | 511 | 432 | $9K | |
| 87340 | 689 | 594 | $9K | |
| 71045 | Radiologic examination, chest; single view | 4,738 | 3,910 | $9K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 207 | 185 | $9K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 52 | 51 | $9K |
| 83550 | 677 | 590 | $8K | |
| 87522 | Neg quan hep c or qual rna | 150 | 138 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | 330 | 244 | $8K |
| 87660 | 607 | 509 | $8K | |
| 80320 | 814 | 575 | $8K | |
| 83540 | 745 | 643 | $8K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 648 | 399 | $7K |
| 97162 | 166 | 137 | $7K | |
| 82746 | 542 | 470 | $7K | |
| 73562 | 301 | 252 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,935 | 2,538 | $7K |
| 87186 | 665 | 486 | $7K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 36 | 13 | $6K |
| 87510 | 607 | 509 | $6K | |
| 94664 | 1,044 | 760 | $6K | |
| 86403 | 304 | 196 | $6K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 343 | 317 | $6K |
| 73610 | 359 | 312 | $6K | |
| 97113 | 76 | 27 | $6K | |
| 82570 | 707 | 566 | $6K | |
| 80306 | 301 | 246 | $6K | |
| 84460 | 579 | 498 | $5K | |
| 73130 | 407 | 338 | $5K | |
| 76642 | 53 | 42 | $5K | |
| 83880 | 900 | 688 | $5K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 365 | 308 | $5K |
| 83735 | 2,333 | 1,568 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,233 | 7,118 | $4K |
| 85652 | 583 | 467 | $4K | |
| 84450 | 539 | 465 | $4K | |
| 83970 | 109 | 88 | $4K | |
| 80076 | 674 | 486 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6,610 | 2,861 | $4K |
| 93971 | 57 | 54 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,790 | 4,090 | $3K |
| 83516 | 188 | 90 | $3K | |
| 73030 | 200 | 149 | $3K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 13 | 12 | $3K |
| 85610 | 1,783 | 1,194 | $3K | |
| 83690 | 4,565 | 3,413 | $3K | |
| 72100 | 98 | 75 | $3K | |
| 71250 | 33 | 30 | $3K | |
| 87077 | 297 | 227 | $2K | |
| 83605 | 2,055 | 1,271 | $2K | |
| 73110 | 167 | 131 | $2K | |
| 84146 | 123 | 90 | $2K | |
| 82043 | 295 | 248 | $2K | |
| 82947 | 1,254 | 623 | $2K | |
| 96376 | 894 | 465 | $2K | |
| 82805 | 42 | 27 | $1K | |
| 81003 | 514 | 353 | $1K | |
| 87081 | 64 | 51 | $1K | |
| 82784 | 115 | 91 | $1K | |
| 96367 | 65 | 41 | $1K | |
| 84153 | 54 | 51 | $1K | |
| 51798 | 71 | 53 | $1K | |
| 70498 | 67 | 39 | $978.45 | |
| 84156 | 258 | 192 | $954.31 | |
| 73502 | 48 | 28 | $934.88 | |
| 82248 | 56 | 54 | $932.60 | |
| 83001 | 51 | 39 | $904.40 | |
| 85730 | 339 | 251 | $871.63 | |
| 85379 | 773 | 568 | $860.69 | |
| 87088 | 99 | 85 | $754.31 | |
| 87205 | 180 | 103 | $720.65 | |
| 76830 | Ultrasound, transvaginal | 31 | 26 | $681.19 |
| 81025 | 1,581 | 1,097 | $617.27 | |
| 84550 | 152 | 111 | $612.37 | |
| 87210 | 57 | 39 | $606.06 | |
| 73590 | 38 | 28 | $597.83 | |
| 87040 | 703 | 290 | $556.87 | |
| 83002 | 32 | 24 | $541.35 | |
| 82565 | 60 | 52 | $461.92 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 12 | 12 | $364.94 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 87 | 86 | $355.59 |
| 80143 | 533 | 407 | $308.04 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 32 | 14 | $305.74 |
| 84100 | 55 | 37 | $270.17 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 967 | 498 | $267.23 |
| 87807 | 510 | 410 | $259.74 | |
| 82670 | 14 | 13 | $234.52 | |
| 90715 | 12 | 12 | $227.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,775 | 3,086 | $212.23 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 721 | 414 | $146.25 |
| 84481 | 16 | 16 | $132.06 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,007 | 2,914 | $127.78 |
| 80179 | 505 | 390 | $95.68 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 48 | 12 | $91.78 |
| 82533 | 14 | 12 | $79.52 | |
| 82150 | 61 | 52 | $78.98 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,378 | 3,574 | $76.03 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 160 | 110 | $74.30 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 13 | 12 | $59.71 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 111 | 42 | $57.50 |
| J2060 | Injection, lorazepam, 2 mg | 396 | 208 | $54.21 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,695 | 947 | $45.48 |
| 94761 | 756 | 266 | $37.29 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 69 | 41 | $34.86 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 686 | 412 | $32.63 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,865 | 1,029 | $32.19 |
| J2704 | Injection, propofol, 10 mg | 1,986 | 938 | $22.98 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 146 | 84 | $20.99 |
| J0690 | Injection, cefazolin sodium, 500 mg | 623 | 367 | $15.86 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 204 | 112 | $14.62 |
| J3370 | Injection, vancomycin hcl, 500 mg | 44 | 12 | $5.78 |
| J8540 | Dexamethasone, oral, 0.25 mg | 13 | 13 | $4.82 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 842 | 529 | $3.96 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 16 | 12 | $3.70 |
| J7050 | Infusion, normal saline solution, 250 cc | 44 | 35 | $1.96 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 243 | 215 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 310 | 135 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 123 | 97 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 104 | 72 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 156 | 109 | $0.00 |
| C1769 | Guide wire | 46 | 26 | $0.00 |
| 73560 | 14 | 13 | $0.00 | |
| J2785 | Injection, regadenoson, 0.1 mg | 95 | 65 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 56 | 12 | $0.00 |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 117 | 108 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 16 | 15 | $0.00 |
| 99152 | 40 | 37 | $0.00 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 154 | 128 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 22 | 13 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 68 | 40 | $0.00 |